AK Medical Holdings Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Zhijiang Li

Chief Executive Officer (CEO)

CN¥1.1m

Compensación total

Porcentaje del salario del CEO	74.9%
Permanencia del CEO	9.3yrs
Participación del CEO	45.0%
Permanencia media de la dirección	3.9yrs
Promedio de permanencia en la Junta Directiva	8.8yrs

Actualizaciones recientes de la dirección

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Jun 11

Recent updates

AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar

Nov 18

AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price

Aug 30

Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge

Jun 20

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Jun 11

Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture

May 27

We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt

May 08

Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects

Apr 21

AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year

Apr 01

AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business

Jan 22

Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price

Jan 04

Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital

Jun 07

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

May 18

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Feb 13

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Nov 10

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Sep 29

Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital

Aug 04

Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?

Jun 25

There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital

Apr 11

Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal

Oct 08

Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)

Sep 20

Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be

Jul 27

I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut

Jul 19

AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jun 16

The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence

Jun 01

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Zhijiang Li en comparación con los beneficios de AK Medical Holdings?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2024	n/a	n/a	CN¥189m
Mar 31 2024	n/a	n/a	CN¥185m
Dec 31 2023	CN¥1m	CN¥814k	CN¥182m
Sep 30 2023	n/a	n/a	CN¥197m
Jun 30 2023	n/a	n/a	CN¥211m
Mar 31 2023	n/a	n/a	CN¥208m
Dec 31 2022	CN¥972k	CN¥806k	CN¥205m
Sep 30 2022	n/a	n/a	CN¥156m
Jun 30 2022	n/a	n/a	CN¥107m
Mar 31 2022	n/a	n/a	CN¥100m
Dec 31 2021	CN¥913k	CN¥800k	CN¥93m
Sep 30 2021	n/a	n/a	CN¥178m
Jun 30 2021	n/a	n/a	CN¥263m
Mar 31 2021	n/a	n/a	CN¥288m
Dec 31 2020	CN¥524k	CN¥430k	CN¥314m
Sep 30 2020	n/a	n/a	CN¥307m
Jun 30 2020	n/a	n/a	CN¥300m
Mar 31 2020	n/a	n/a	CN¥284m
Dec 31 2019	CN¥1m	CN¥779k	CN¥267m
Sep 30 2019	n/a	n/a	CN¥235m
Jun 30 2019	n/a	n/a	CN¥203m
Mar 31 2019	n/a	n/a	CN¥174m
Dec 31 2018	CN¥1m	CN¥764k	CN¥145m
Sep 30 2018	n/a	n/a	CN¥136m
Jun 30 2018	n/a	n/a	CN¥127m
Mar 31 2018	n/a	n/a	CN¥116m
Dec 31 2017	CN¥776k	CN¥765k	CN¥105m

Compensación vs. Mercado: La compensación total de Zhijiang($USD150.02K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD481.54K).

Compensación vs. Ingresos: La compensación de Zhijiang ha sido consistente con los resultados de la empresa en el último año.

CEO

Zhijiang Li (56 yo)

9.3yrs

Permanencia

CN¥1,087,000

Compensación

Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhijiang Li	Chairman & CEO	no data	CN¥1.09m	45% HK$ 2.5b
Bin Mo Zhang	Senior VP & Executive Director	8.6yrs	CN¥193.00k	0.90% HK$ 50.4m
Chaoyang Zhang	Senior VP & Executive Director	8.6yrs	CN¥1.19m	5.24% HK$ 292.9m
Xiaohong Zhao	Executive Director	no data	CN¥1.57m	0.19% HK$ 10.6m
Kun Liang	Chief Financial Officer	3.9yrs	sin datos	sin datos
Hanzhong Sun	Vice President of Human Resources	3.5yrs	sin datos	sin datos
Rongkun Ma	Company Secretary	less than a year	sin datos	sin datos

3.9yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 1789 se considera experimentado (3.9 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhijiang Li	Chairman & CEO	9.3yrs	CN¥1.09m	45% HK$ 2.5b
Bin Mo Zhang	Senior VP & Executive Director	9.3yrs	CN¥193.00k	0.90% HK$ 50.4m
Chaoyang Zhang	Senior VP & Executive Director	9.3yrs	CN¥1.19m	5.24% HK$ 292.9m
Xiaohong Zhao	Executive Director	8.8yrs	CN¥1.57m	0.19% HK$ 10.6m
David Wang	Non-Executive Director	8.8yrs	sin datos	sin datos
Chi Mo Kong	Independent Non-Executive Director	7yrs	CN¥178.00k	sin datos
Shu Wing Li	Independent Non-Executive Director	7yrs	CN¥178.00k	sin datos
Wei Gao	Independent Non-Executive Director	less than a year	sin datos	sin datos

8.8yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de 1789 se considera experimentada (8.8 años de antigüedad promedio).

AK Medical Holdings Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

AK Medical Holdings Limited Announces Change of Company Secretary, with Effect from 30 August 2024

AK Medical Holdings Limited Appoints Gao Wei as Independent Non-Executive Director

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Eric Wang to Retire as an Independent Non-Executive Director of AK Medical Holdings Limited

AK Medical Holdings Limited, Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Recent updates

AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar

Investor sentiment improves as stock rises 21%

First half 2024 earnings: Revenues and EPS in line with analyst expectations

AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price

First half 2024 earnings: Revenues and EPS in line with analyst expectations

AK Medical Holdings Limited Announces Change of Company Secretary, with Effect from 30 August 2024

Investor sentiment deteriorates as stock falls 17%

AK Medical Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024

Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge

AK Medical Holdings Limited Appoints Gao Wei as Independent Non-Executive Director

Upcoming dividend of HK$0.045 per share

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture

Now 22% undervalued

We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt

Now 25% undervalued

Investor sentiment improves as stock rises 20%

Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects

Eric Wang to Retire as an Independent Non-Executive Director of AK Medical Holdings Limited

Investor sentiment improves as stock rises 16%

Consensus revenue estimates fall by 11%

AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year

Dividend of HK$0.045 announced

AK Medical Holdings Limited, Annual General Meeting, Jun 18, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

AK Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024

AK Medical Holdings Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Ak Medical Holdings Limited Obtains the Certification from National Medical Products Administration

AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Now 27% undervalued after recent price drop

Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price

AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly

AK Medical Holdings Limited Obtains the Certification for Acetabular Component of Hip Prosthesis Class III Medical Devices Approved by the National Medical Products Administration

Consensus EPS estimates fall by 11%

A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Investor sentiment improves as stock rises 16%

AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital

AK Medical Holdings (HKG:1789) Could Easily Take On More Debt

First half 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.11 in 1H 2022)

New major risk - Earnings quality

Investor sentiment deteriorates as stock falls 19%

AK Medical Holdings Limited to Report Q2, 2023 Results on Aug 22, 2023

Upcoming dividend of HK$0.06 per share at 0.8% yield

Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital

Investor sentiment deteriorates as stock falls 15%

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Full year 2022 earnings: Revenues in line with analyst expectations

AK Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022

AK Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

AK Medical Holdings Limited Obtains the Certification for the Dental Implant System Class III Medical Devices Approved by the National Medical Products Administration

Less than half of directors are independent

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Investor sentiment deteriorated over the past week

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Investor sentiment improved over the past week

First half 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1H 2021)

Investor sentiment improved over the past week

Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital

Consensus forecasts updated

AK Medical Holdings Limited to Report First Half, 2022 Results on Aug 30, 2022

Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?

Investor sentiment improved over the past week

AK Medical Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Upcoming dividend of HK$0.025 per share

Investor sentiment improved over the past week

Less than half of directors are independent

There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital